Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients With BCR-ABL-Negative Acute Lymphoblastic Leukemia

NCT00131053 is registered in ClinicalTrials.gov with Japan Adult Leukemia Study Group as lead sponsor.

NCT NCT00131053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00131053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients With BCR-ABL-Negative Acute Lymphoblastic Leukemia
Lead sponsor
Japan Adult Leukemia Study Group
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2002
Completion date
September 30, 2011
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic leukemia, acute